Pfizer Ltd

Pfizer Management Change

Pfizer Limited announced the resignation of Mr. Sharad Goswami, Senior Director – Policy & Public Affairs, effective from the close of business on September 25, 2026.

Pfizer Board Meeting Outcome

Pfizer Board approved discontinuation of Minipress XL effective September 7, 2026. The company will receive ₹131.38 Crore lump-sum payment from Pfizer Inc., USA.

Value

₹131.4 Cr

Pfizer Annual General Meeting

Pfizer Limited held its 75th Annual General Meeting on July 28, 2026. The meeting covered the adoption of financial statements, dividend declaration, and auditor remuneration ratification.

Pfizer Q1 FY27 Results: Net Profit ₹204.5 Cr, Up 6.6% YoY

Pfizer Ltd reported revenue from operations of ₹653.2 Cr (+8.3% YoY) and net profit of ₹204.5 Cr (+6.6% YoY) for Q1 FY27.

Key figure

Net profit ₹204.5 Cr · +6.6% YoY

Pfizer Management Change

Mr. Amit Agarwal has resigned as the Executive Director – Finance & Chief Financial Officer and Director of Pfizer Limited, effective October 8, 2026.

Pfizer Board Meeting Date

Pfizer Limited has scheduled a board meeting for July 28, 2026, to consider and approve the unaudited standalone financial results for the quarter ended June 2026.

Pfizer Price Movement Clarification

Pfizer clarified that Premarin Vaginal Cream's temporary discontinuation due to supply constraints has no material impact. The product contributes less than 1% of total revenue.